Moderna Inc. buy BMO Capital Markets
Start price
12.01.26
/
50%
€29.02
Target price
12.01.27
-
Performance (%)
24.19%
Price
16.01.26
€36.04
Summary
This prediction is currently active. The prediction currently has a performance of 24.19%. This prediction currently runs until 12.01.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Moderna Inc. | 24.19% |
| iShares Core DAX® | 0.191% |
| iShares Nasdaq 100 | -0.614% |
| iShares Nikkei 225® | 0.599% |
| iShares S&P 500 | -0.036% |
Comments by BMO_Capital_Markets for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
Ratings data for MRNA provided by MarketBeat